ATP13A2 and Parkinson disease: In 2024, an Atp13a2 KO mouse model injected with α-syn pre-formed fibrils (PFF) of α-syn in the striatum was used to induce α-syn-related PD pathology, a strategy implemented in the present study through viral-based A53T α-syn overexpression.